Modalis Therapeutics

4883.TTSE GROWTHPharmaceutical

In English · 74

Thu, Oct 22 · JST1 filing

11:205% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 8.96% → 7.61%−1.35pp

Fri, Sep 18 · JST1 filing

14:205% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 10.28% → 9.02%−1.26pp

Thu, Sep 17 · JST1 filing

10:115% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 14.23% → 10.28%−3.95pp

Tue, Aug 18 · JST1 filing

11:305% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 16.20% → 15.16%−1.04pp

Thu, Jul 30 · JST1 filing

15:475% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 17.46% → 16.20%−1.26pp

Tue, Jul 21 · JST1 filing

12:085% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 19.07% → 17.46%−1.61pp

Mon, Jul 13 · JST1 filing

13:435% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 20.19% → 19.07%−1.12pp

Fri, Jul 10 · JST1 filing

15:005% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 21.49% → 20.19%−1.30pp

Mon, Jul 6 · JST1 filing

14:255% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 22.69% → 21.49%−1.20pp

Fri, Jun 19 · JST1 filing

16:315% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 22.69%new 22.69%

Wed, May 27 · JST1 filing

16:105% STAKEModalis Therapeutics · LSIM Inc. + 1 joint holder · 5.63% → 5.39%−0.24pp

Fri, May 1 · JST2 filings

12:175% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 4.99% → 4.00%−0.99pp 11:455% STAKEModalis Therapeutics · LSIM Inc. + 1 joint holder · 6.75% → 5.63%−1.12pp

Fri, Apr 24 · JST1 filing

12:185% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 5.92% → 4.99%−0.93pp

Wed, Apr 15 · JST1 filing

12:005% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 7.13% → 5.92%−1.21pp

Fri, Apr 3 · JST1 filing

12:185% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 8.26% → 7.13%−1.13pp

Thu, Mar 12 · JST1 filing

12:195% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 9.63% → 8.26%−1.37pp

Thu, Mar 5 · JST1 filing

10:545% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 10.53% → 9.63%−0.90pp

Tue, Feb 24 · JST1 filing

11:195% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 11.56% → 10.53%−1.03pp

Mon, Feb 2 · JST1 filing

12:315% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 12.45% → 11.56%−0.89pp

Mon, Jan 5 · JST1 filing

12:485% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 13.13% → 12.45%−0.68pp

Wed, Dec 17 · JST1 filing

12:275% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 13.86% → 13.13%−0.73pp

Fri, Dec 5 · JST1 filing

11:305% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 14.79% → 13.86%−0.93pp

Wed, Nov 19 · JST1 filing

13:005% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 15.09% → 14.79%−0.30pp

Tue, Nov 18 · JST1 filing

10:305% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 16.02% → 15.09%−0.93pp

Mon, Nov 10 · JST1 filing

11:055% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 16.79% → 16.02%−0.77pp

Wed, Oct 22 · JST1 filing

11:465% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 17.80% → 16.79%−1.01pp

Thu, Oct 16 · JST1 filing

14:285% STAKEModalis Therapeutics · LSIM Inc. + 1 joint holder · 6.75% → 6.75%

Tue, Sep 9 · JST1 filing

14:295% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 18.47% → 17.80%−0.67pp

Fri, Sep 5 · JST1 filing

12:205% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 19.17% → 18.47%−0.70pp

Mon, Sep 1 · JST1 filing

15:515% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 19.17%new 19.17%

Tue, Aug 12 · JST1 filing

12:065% STAKEModalis Therapeutics · Life Science Innovation Management Inc. + 1 joint holder · 6.75% → 6.75%

Fri, May 30 · JST1 filing

16:015% STAKEModalis Therapeutics · Life Science Innovation Management Inc. + 1 joint holder · 4.26% → 6.75%+2.49pp

Fri, May 23 · JST1 filing

15:275% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 5.72% → 4.36%−1.36pp

Fri, May 2 · JST1 filing

16:005% STAKEModalis Therapeutics · Life Science Innovation Management Inc. + 1 joint holder · 8.10% → 4.26%−3.84pp

Mon, Apr 28 · JST1 filing

14:395% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 6.75% → 5.72%−1.03pp

Thu, Apr 17 · JST1 filing

12:065% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 7.79% → 6.75%−1.04pp

Fri, Feb 21 · JST1 filing

15:31MATERIALModalis Therapeutics · Change of independent auditor

Fri, Feb 14 · JST1 filing

12:565% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 9.06% → 7.79%−1.27pp

Fri, Jan 31 · JST1 filing

13:345% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 10.15% → 9.06%−1.09pp

Thu, Jan 30 · JST1 filing

13:555% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 12.12% → 10.15%−1.97pp

Wed, Jan 22 · JST1 filing

15:535% STAKEModalis Therapeutics · SBI SECURITIES Co., Ltd. + 1 joint holder · 5.05%new 5.05%

Mon, Dec 23 · JST1 filing

16:555% STAKEModalis Therapeutics · SBI SECURITIES Co., Ltd. + 1 joint holder · 5.04%new 5.04%

Fri, Nov 22 · JST1 filing

16:275% STAKEModalis Therapeutics · SBI SECURITIES Co., Ltd. + 1 joint holder · 5.36%new 5.36%

Wed, Nov 6 · JST1 filing

13:555% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 13.54% → 12.12%−1.42pp

Tue, Nov 5 · JST1 filing

14:415% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 17.69% → 13.54%−4.15pp

Fri, Oct 18 · JST1 filing

12:145% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 17.74% → 17.69%−0.05pp

Wed, Oct 16 · JST1 filing

16:315% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 18.51% → 17.74%−0.77pp

Tue, Oct 15 · JST1 filing

12:415% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 19.88% → 18.51%−1.37pp

Thu, Oct 10 · JST1 filing

15:485% STAKEModalis Therapeutics · SBI SECURITIES Co., Ltd. + 1 joint holder · 5.38% → 4.36%−1.02pp

Wed, Oct 9 · JST1 filing

12:515% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 20.58% → 19.88%−0.70pp

Tue, Oct 8 · JST1 filing

12:555% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 21.60% → 20.58%−1.02pp

Fri, Sep 27 · JST1 filing

13:145% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 22.88% → 21.60%−1.28pp

Thu, Sep 26 · JST1 filing

12:195% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 25.92% → 22.88%−3.04pp

Wed, Sep 25 · JST2 filings

14:535% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 28.00% → 25.92%−2.08pp 10:035% STAKEModalis Therapeutics · Osamu Nureki · 5.11% → 3.58%−1.53pp

Fri, Sep 20 · JST1 filing

12:425% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 28.72% → 28.00%−0.72pp

Tue, Sep 17 · JST1 filing

12:085% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 28.64% → 28.72%+0.08pp

Thu, Sep 12 · JST1 filing

11:575% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 29.59% → 28.64%−0.95pp

Tue, Sep 10 · JST1 filing

12:075% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 29.54% → 29.59%+0.05pp

Mon, Sep 9 · JST1 filing

15:385% STAKEModalis Therapeutics · SBI Investment Co., Ltd. + 1 joint holder · 5.04%new 5.04%

Thu, Sep 5 · JST1 filing

10:355% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 30.25% → 29.54%−0.71pp

Mon, Sep 2 · JST1 filing

12:055% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 31.76% → 30.25%−1.51pp

Fri, Aug 30 · JST1 filing

15:095% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 5.42% → 31.76%+26.34pp

Wed, Aug 28 · JST1 filing

11:235% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 6.54% → 5.42%−1.12pp

Tue, Aug 20 · JST1 filing

10:275% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 6.26% → 6.54%+0.28pp

Mon, Aug 19 · JST1 filing

12:005% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 7.74% → 6.26%−1.48pp

Fri, Aug 16 · JST1 filing

15:155% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 10.84% → 7.74%−3.10pp

Fri, Aug 9 · JST1 filing

11:345% STAKEModalis Therapeutics · Life Science Innovation Management Inc. + 1 joint holder · 10.12% → 8.10%−2.02pp

Wed, Aug 7 · JST1 filing

16:265% STAKEModalis Therapeutics · SBI Investment Co., Ltd. + 1 joint holder · 5.17% → 4.04%−1.13pp

Fri, Aug 2 · JST2 filings

10:495% STAKEModalis Therapeutics · Osamu Nureki · 6.13% → 5.11%−1.02pp 10:425% STAKEModalis Therapeutics · NUREKI OSAMU · 8.49% → 6.13%−2.36pp

Wed, Jul 31 · JST1 filing

11:035% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 11.95% → 10.84%−1.11pp

Fri, Jul 19 · JST1 filing

11:515% STAKEModalis Therapeutics · Evo Fund + 1 joint holder · 15.95% → 11.95%−4.00pp

All EDINET filings · 204

All Financial 23 5% 157 Material 3 Other 21

Filed	Document	Filer	Source
2026-09-28	Large shareholding reportRelated to S100YEWZ	Evo Fund	S100Z3TU
2026-09-18	Large shareholding reportRelated to S100YEWZ	Evo Fund	S100Z313
2026-09-17	Large shareholding reportRelated to S100YEWZ	Evo Fund	S100Z2PI
2026-09-07	Large shareholding reportRelated to S100YEWZ	Evo Fund	S100Z0R9
2026-08-18	Large shareholding reportRelated to S100YEWZ	Evo Fund	S100YXCM
2026-08-14	CEO/CFO certification	Modalis Therapeutics Corporation	S100YWX5
2026-08-14	Half-year report	Modalis Therapeutics Corporation	S100YVRI
2026-07-30	Large shareholding reportRelated to S100YEWZ	Evo Fund	S100YSUG
2026-07-21	Large shareholding reportRelated to S100YEWZ	Evo Fund	S100YQV7
2026-07-13	Large shareholding reportRelated to S100YEWZ	Evo Fund	S100YQ3G
2026-07-10	Large shareholding reportRelated to S100YEWZ	Evo Fund	S100YPRV
2026-07-06	Large shareholding reportRelated to S100YEWZ	Evo Fund	S100YOYT
2026-06-19	Large shareholding report	Evo Fund	S100YEWZ
2026-05-27	Large shareholding report	Morita Haruhiko	S100Y6TX
2026-05-27	Securities registration	Modalis Therapeutics Corporation	S100Y6SQ
2026-05-01	Large shareholding reportRelated to S100WMC3	Evo Fund	S100Y1SX
2026-05-01	Large shareholding report	Morita Haruhiko	S100Y11S
2026-04-24	Large shareholding reportRelated to S100WMC3	Evo Fund	S100Y0IS
2026-04-15	Large shareholding reportRelated to S100WMC3	Evo Fund	S100XYTZ
2026-04-03	Large shareholding reportRelated to S100WMC3	Evo Fund	S100XWNF
2026-03-27	Material event report	Modalis Therapeutics Corporation	S100XUXP
2026-03-25	Internal control report	Modalis Therapeutics Corporation	S100XSHR
2026-03-25	CEO/CFO certification	Modalis Therapeutics Corporation	S100XSHP
2026-03-25	Annual report	Modalis Therapeutics Corporation	S100XSHO
2026-03-12	Large shareholding reportRelated to S100WMC3	Evo Fund	S100XPZT
2026-03-05	Large shareholding reportRelated to S100WMC3	Evo Fund	S100XOT7
2026-02-24	Large shareholding reportRelated to S100WMC3	Evo Fund	S100XMKM
2026-02-02	Large shareholding reportRelated to S100WMC3	Evo Fund	S100XHZ0
2026-01-05	Large shareholding reportRelated to S100WMC3	Evo Fund	S100XDQ1
2025-12-17	Large shareholding reportRelated to S100WMC3	Evo Fund	S100XAUO

EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 8 financial reports not structured yet.

Not structured yet

2022-03-31	quarterly	original indexed	S100O0O8
2021-12-31	annual	original indexed	S100NRUN
2021-09-30	quarterly	original indexed	S100MUON
2021-06-30	quarterly	original indexed	S100M9R7
2021-03-31	quarterly	original indexed	S100LBPB
2020-12-31	annual	original indexed	S100L3EV
2020-09-30	quarterly	original indexed	S100K5MH
2020-06-30	quarterly	original indexed	S100JJV8